•Lipodystrophies are a heterogeneous group of diseases characterized by abnormal fat distribution.
•Familial partial lipodystrophy 2 (FPLD2) is autosomal dominant condition due to mutations in the LMNA gene.
•It is characterized by selective loss of subcutaneous adipose tissue from the limbs and trunk, and accumulation of fat in the neck and face.
•Usually associated with a variety of metabolic disorders including insulin resistance, diabetes mellitus, dyslipidemia, hepatic steatosis and high blood pressure.
To study the clinical and molecular features of 2 subjects with FPLD.
OBJECTIVES
Utilizing Next Generation Sequencing (NGS) we carried out mutational analysis of LMNA gene in a woman and her daughter with FPLD phenotype •Both subjects also had elevated C-peptide levels and HOMA-IR suggestive of insulin resistance, and Dual energy X-ray absorptiometry showed increased fat in the face with decreased limb fat confirming fat redistribution. Further, genetic testing helped in confirming the diagnosis.
SUBJECTS AND METHODS

RESULTS OF GENETIC TESTS
CONCLUSIONS
•With this diagnosis, Metformin was added and better glycaemic control was achieved.
CLINICAL PRESENTATION MOTHER AND DAUGHTER
•Diabetes detected less than 30 years of age. 
